Article Detail - JA DME
October 2024 HCPCS Updates
CMS has released the October 2024 Healthcare Common Procedure Coding System (HCPCS) file. Inclusion on this list does not indicate coverage. All HCPCS code changes are effective and should be used for claims with dates of service on or after October 1, 2024. Watch the Noridian website for additional policy updates regarding these HCPCS codes.
Added HCPCS Codes
Effective for dates of service on and after October 1, 2024
| HCPCS | DESCRIPTION |
|---|---|
| A4543 | Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month |
| A4544 | Electrode for external lower extremity nerve stimulator for restless legs syndrome |
| A4545 | Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month |
| A7021 | Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter) |
| A9610 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
| E0469 | Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device |
| E0683 | Non-pneumatic, non-sequential, peristaltic wave compression pump |
| E0715 | Intravaginal device intended to strengthen pelvic floor muscles during kegel exercises |
| E0716 | Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises |
| E0721 | Transcutaneous electrical nerve stimulatory, stimulates nerves in the auricular region |
| E0737 | Transcutaneous tibial nerve stimulator, controlled by phone application |
| E0743 | External lower extremity nerve stimulator for restless legs syndrome, each |
| E0767 | Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories |
| E2513 | Accessory for speech generating device, electromyographic sensor |
| E3200 | Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only |
| J0138 | Injection, acetaminophen 10 mg and ibuprofen 3 mg |
| J1171 | Injection, hydromorphone, 0.1 mg |
| J1749 | Injection, iloprost, 0.1 mcg |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg |
| J2003 | Injection, lidocaine hydrochloride, 1 mg |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg |
| J2252 | Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg |
| J2253 | Injection, midazolam (seizalam), 1 mg |
| J2601 | Injection, vasopressin (baxter), 1 unit |
| J8522 | Capecitabine, oral, 50 mg |
| J8541 | Dexamethasone (hemady), oral, 0.25 mg |
| J9329 | Injection, tislelizumab-jsgr, 1mg |
| L1006 | Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
| L1653 | Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf |
| L1821 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf |
| L8720 | External lower extremity sensory prosthesis, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg |
| L8721 | Receptor sole for use with l8720, replacement, each |
Description Update
The long description of the HCPCS code has been updated as of October 1, 2024
| HCPCS | DESCRIPTION |
|---|---|
| A4271 | Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per 50 tests |
| E0739 | Rehabilitation system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors |
| J2251 | Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg |
| J9172 | Injection, docetaxel (docivyx), 1 mg |
| L1652 | Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
| L1820 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
| Q0516 | Pharmacy supplying fee for HIV pre-exposure prophylaxis FDA approved prescription oral drug, per 30-days |
| Q0517 | Pharmacy supplying fee for HIV pre-exposure prophylaxis FDA approved prescription oral drug, per 60-days |
| Q0518 | Pharmacy supplying fee for HIV pre-exposure prophylaxis FDA approved prescription oral drug, per 90-days |
Deleted HCPCS Code
Invalid for billing for dates of service October 1, 2024 and after
| HCPCS | DESCRIPTION |
|---|---|
| J1170 | INJECTION, HYDROMORPHONE, UP TO 4 MG |
| J2001 | INJECTION, LIDOCAINE HCL FOR INTRAVENOUS INFUSION, 10 MG |
| J8520 | CAPECITABINE, ORAL, 150 MG |
| J8521 | CAPECITABINE, ORAL, 500 MG |
| J9258 | INJECTION, PACLITAXEL PROTEIN-BOUND PARTICLES (TEVA), NOT THERAPEUTICALLY EQUIVALENT TO J9264, 1 MG |
Last Updated Sep 12 , 2024
